These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26440302)

  • 1. Pharmacokinetic Characteristics and Clinical Outcomes of Vancomycin in Young Children With Various Degrees of Renal Function.
    Zhang H; Wang Y; Gao P; Hu J; Chen Y; Zhang L; Shen X; Xu H; Xu Q
    J Clin Pharmacol; 2016 Jun; 56(6):740-8. PubMed ID: 26440302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.
    Ploessl C; White C; Manasco K
    Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
    Cies JJ; Moore WS; Nichols K; Knoderer CA; Carella DM; Chopra A
    Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
    Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
    Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of serum creatinine measurements on GFR estimation and vancomycin dosing in children.
    Neuman G; Nulman I; Adeli K; Koren G; Colantonio DA; Helldén A
    J Clin Pharmacol; 2014 Jul; 54(7):785-91. PubMed ID: 24596064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin dosing and target attainment in children.
    Hwang D; Chiu NC; Chang L; Peng CC; Huang DT; Huang FY; Chi H
    J Microbiol Immunol Infect; 2017 Aug; 50(4):494-499. PubMed ID: 26462708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis.
    Zhang Y; Wang T; Zhang D; You H; Dong Y; Liu Y; Du Q; Sun D; Zhang T; Dong Y
    Ther Drug Monit; 2020 Aug; 42(4):600-609. PubMed ID: 32097248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Initial Trough Concentrations of Vancomycin with Outcomes in Pediatric Patients with Gram-Positive Bacterial Infection.
    Kondo M; Nakagawa S; Orii S; Itohara K; Sugimoto M; Omura T; Sato Y; Imai S; Yonezawa A; Nakagawa T; Matsubara K
    Biol Pharm Bull; 2020; 43(10):1463-1468. PubMed ID: 32999156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin serum concentrations in pediatric oncologic/hematologic intensive care patients.
    Silva DC; Seixas GT; Araujo OR; Arduini RG; Carlesse FA; Petrilli AS
    Braz J Infect Dis; 2012; 16(4):361-5. PubMed ID: 22846125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Pharmacokinetics of Vancomycin in Critically Ill Children.
    Sridharan K; Al Daylami A; Ajjawi R; Al-Ajooz H; Veeramuthu S
    Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):807-816. PubMed ID: 31301023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing the Clinical Use of Vancomycin.
    Álvarez R; López Cortés LE; Molina J; Cisneros JM; Pachón J
    Antimicrob Agents Chemother; 2016 May; 60(5):2601-9. PubMed ID: 26856841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revising Pediatric Vancomycin Dosing Accounting for Nephrotoxicity in a Pharmacokinetic-Pharmacodynamic Model.
    Kloprogge F; Hill LF; Booth J; Klein N; Irwin AD; Dixon G; Standing JF
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30833429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular filtration rate equations do not accurately predict vancomycin trough concentrations in pediatric patients.
    Alford EL; Chhim RF; Crill CM; Hastings MC; Ault BH; Shelton CM
    Ann Pharmacother; 2014 Jun; 48(6):691-6. PubMed ID: 24646680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of vancomycin in Chinese patients with augmented renal clearance.
    Chu Y; Luo Y; Ji S; Jiang M; Zhou B
    J Infect Public Health; 2020 Jan; 13(1):68-74. PubMed ID: 31277936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit.
    Cies JJ; Shankar V
    Pharmacotherapy; 2013 Apr; 33(4):392-400. PubMed ID: 23471688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of vancomycin protein binding on target attainment in critically ill children: back to the drawing board?
    De Cock PA; Desmet S; De Jaeger A; Biarent D; Dhont E; Herck I; Vens D; Colman S; Stove V; Commeyne S; Vande Walle J; De Paepe P
    J Antimicrob Chemother; 2017 Mar; 72(3):801-804. PubMed ID: 27999035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients.
    Avedissian SN; Bradley E; Zhang D; Bradley JS; Nazer LH; Tran TM; Nguyen A; Le J
    Pediatr Crit Care Med; 2017 Sep; 18(9):e388-e394. PubMed ID: 28640009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit.
    Qian X; Du G; Weng C; Zhou H; Zhou X
    Int J Infect Dis; 2017 Jul; 60():17-22. PubMed ID: 28457752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of serum vancomycin concentrations in pediatric patients with normal renal function.
    Khotaei GT; Jam S; SeyedAlinaghi S; Motamed F; Nejat F; Taghi M; Ashtiani H; Izadyar M
    Acta Med Iran; 2010; 48(2):91-4. PubMed ID: 21133000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
    Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
    Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.